AMICUS THERAPEUTICS INC. - COMMON STOCK
9.7700
14-February-25 15:45:00
15 minutes delayed
Stocks
+0.1300
+1.35%
Today's range
9.6500 - 9.8200
ISIN
N/A
Source
NASDAQ
-
NetDania - New 12 months Low: AMICUS THERAPEUTICS INC. - COMMON STOCK
10 May 2024 09:37:34 By NetDania Notify
-
NetDania - New 12 months Low: AMICUS THERAPEUTICS INC. - COMMON STOCK
09 May 2024 08:48:15 By NetDania Notify
-
Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates
09 May 2024 06:00:01 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference
08 May 2024 06:00:01 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024
01 May 2024 06:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
20 Mar 2024 06:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
01 Mar 2024 06:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
28 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
15 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
08 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024
01 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
07 Jan 2024 15:00:52 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 06:00:00 By Nasdaq GlobeNewswire
-
05 Dec 2023 05:00:38 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates
08 Nov 2023 06:00:01 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023
01 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023
27 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Presentation and Posters at World Muscle Society 2023
03 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration
02 Oct 2023 07:20:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease
28 Sep 2023 09:41:45 By Nasdaq GlobeNewswire